EP4565216A4 - Systeme und verfahren zur transdermalen pflasterverabreichung - Google Patents

Systeme und verfahren zur transdermalen pflasterverabreichung

Info

Publication number
EP4565216A4
EP4565216A4 EP23850877.4A EP23850877A EP4565216A4 EP 4565216 A4 EP4565216 A4 EP 4565216A4 EP 23850877 A EP23850877 A EP 23850877A EP 4565216 A4 EP4565216 A4 EP 4565216A4
Authority
EP
European Patent Office
Prior art keywords
systems
methods
transdermal patch
patch administration
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23850877.4A
Other languages
English (en)
French (fr)
Other versions
EP4565216A2 (de
Inventor
Stuart Jones
Mohamed Alhnan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitamax Patch Wholesaler LLC
Original Assignee
Vitamax Patch Wholesaler LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitamax Patch Wholesaler LLC filed Critical Vitamax Patch Wholesaler LLC
Publication of EP4565216A2 publication Critical patent/EP4565216A2/de
Publication of EP4565216A4 publication Critical patent/EP4565216A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP23850877.4A 2022-08-01 2023-07-31 Systeme und verfahren zur transdermalen pflasterverabreichung Pending EP4565216A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263394219P 2022-08-01 2022-08-01
PCT/US2023/071320 WO2024030855A2 (en) 2022-08-01 2023-07-31 Systems and methods for transdermal patch delivery

Publications (2)

Publication Number Publication Date
EP4565216A2 EP4565216A2 (de) 2025-06-11
EP4565216A4 true EP4565216A4 (de) 2026-08-12

Family

ID=89849869

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23850877.4A Pending EP4565216A4 (de) 2022-08-01 2023-07-31 Systeme und verfahren zur transdermalen pflasterverabreichung

Country Status (2)

Country Link
EP (1) EP4565216A4 (de)
WO (1) WO2024030855A2 (de)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000048541A1 (en) * 1999-02-19 2000-08-24 Brooks Norman A Zinc chloride in treating skin diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4334553C2 (de) * 1993-10-11 1998-05-20 Synopharm Gmbh Pharmazeutische Flüssiges pharmazeutisches System zur perkutanen Applikation
US7470266B2 (en) * 2003-09-16 2008-12-30 I-Flow Corporation Fluid medication delivery device
CA2794734C (en) * 2010-03-30 2017-12-12 Phosphagenics Limited Transdermal delivery patch
WO2012092628A2 (en) * 2010-12-31 2012-07-05 Incube Labs, Llc Patches and methods for the transdermal delivery of agents to treat hair loss
AU2017242908B2 (en) * 2016-03-31 2022-11-17 Shield TX (UK) Limited Ferric maltol compositions for use in the treatment or prevention of cancer and tumours
GB202016614D0 (en) * 2020-10-20 2020-12-02 King S College London Compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000048541A1 (en) * 1999-02-19 2000-08-24 Brooks Norman A Zinc chloride in treating skin diseases

Also Published As

Publication number Publication date
WO2024030855A2 (en) 2024-02-08
WO2024030855A3 (en) 2024-03-14
EP4565216A2 (de) 2025-06-11

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20250227

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/70 20060101AFI20260415BHEP

Ipc: A61K 31/593 20060101ALI20260415BHEP

Ipc: A61K 33/04 20060101ALI20260415BHEP

Ipc: A61K 33/06 20060101ALI20260415BHEP

Ipc: A61K 33/26 20060101ALI20260415BHEP

Ipc: A61K 33/30 20060101ALI20260415BHEP

Ipc: A61K 33/34 20060101ALI20260415BHEP

Ipc: A61K 31/661 20060101ALI20260415BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20260715

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/70 20060101AFI20260709BHEP

Ipc: A61K 31/593 20060101ALI20260709BHEP

Ipc: A61K 33/04 20060101ALI20260709BHEP

Ipc: A61K 33/06 20060101ALI20260709BHEP

Ipc: A61K 33/26 20060101ALI20260709BHEP

Ipc: A61K 33/30 20060101ALI20260709BHEP

Ipc: A61K 33/34 20060101ALI20260709BHEP

Ipc: A61K 31/661 20060101ALI20260709BHEP